HomeDigoxinDigoxin + Posaconazole Delayed Release

Does Digoxin Interact with Posaconazole Delayed Release?

Digoxin and Posaconazole Delayed Release have a moderate drug interaction according to U.S. FDA drug labeling data. Monitor digoxin plasma concentrations during posaconazole coadministration. The mechanism involves p-glycoprotein inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Digoxin Class
Cardiac Glycoside
Posaconazole Delayed Release Class
Azole Antifungal
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Digoxin and Posaconazole Delayed Release occurs because p-glycoprotein inhibition. Clinically, this means monitor digoxin plasma concentrations during posaconazole coadministration. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Digoxin and your doctor is considering prescribing Posaconazole Delayed Release (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Digoxin(Digoxin)+💊 Posaconazole Delayed Release(Posaconazole)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Cardiac Glycoside
Drug B class
Azole Antifungal
Source
NLP:posaconazole delayed-release

What this means in plain English

Monitor digoxin plasma concentrations during posaconazole coadministration.

What the FDA label says

"P-glycoprotein inhibition"

📖 Source: NLP:posaconazole delayed-release

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Digoxin and Posaconazole Delayed Release against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.